Back to results
US 2021/0230113 A1Published application
Cannabinoid derivatives
AssigneePerkinElmer Health Sciences, Inc.
InventorCrist Filer
Life of this patent
Estimating the term…
Abstract
This disclosure provides 8,9-dihydrocannabinoid derivatives, deuterated cannabinoid derivatives, and tritiated cannabinoid derivatives. The disclosure also provides compositions, methods of use, and processes of preparation of the foregoing derivatives.
Claims34
A compound selected from the group consisting of
- or a pharmaceutically acceptable salt or solvate thereof.
(canceled)
(canceled)
(canceled)
8-9. (canceled)
11-120. (canceled)
A compound of Formula (1)
- or a pharmaceutically acceptable salt or solvate thereof,
- wherein Y1 and Y2 are each independently hydrogen or deuterium,
- is a single or a double bond,
- and
- Z is —CH2CH3, —CH2CH2CH3, —CH2CH2CH2CH3 or
2 more elements
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A compound of Formula (2)
- or a pharmaceutically acceptable salt or solvate thereof,
- wherein Y1 and Y2 are each independently hydrogen or tritium,
- is a single or a double bond,
- provided that if is a double bond, then Z1 and Z2 are absent,
- and provided that if is a single bond, then Z1 and Z2 are are each independently
- hydrogen or tritium,
- provided that the compound comprises tritium,
- and
- Z is —CH2CH3, —CH2CH2CH3, —CH2CH2CH2CH3 or
6 more elements
(canceled)
(canceled)
(canceled)
(canceled)
144-152. (canceled)
Dependencies are inferred from the claim text.